Invo Bioscience Inc  

(Public, OTCMKTS:IVOB)   Watch this stock  
Find more results for PINK:IVOB
0.000 (0.00%)
Delayed:   12:09PM EDT
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.35 - 0.38
52 week 0.20 - 0.52
Open 0.38
Vol / Avg. 5,295.00/23,947.00
Mkt cap 53.69M
P/E     -
Div/yield     -
EPS -0.01
Shares 141.19M
Beta 1.56
Inst. own 0%

Key stats and ratios

Q4 (Dec '11) 2016
Net profit margin -5093.39% -4173.38%
Operating margin -3981.22% -4146.21%
EBITD margin - -4142.52%
Return on average assets -588.44% -490.58%
Return on average equity - -
Employees 3 -
CDP Score - -


407R Mystic Ave Ste 34C
MEDFORD, MA 02155-6336
United States - Map
+1-978-8789505 (Phone)

Website links


INVO Bioscience, Inc. is a medical device company. The Company is focused on creating various treatments for patients diagnosed with infertility. The Company's product, the INVOcell, is a medical device used in infertility treatment and is considered as an assisted reproductive technology (ART). INVOcell is an intravaginal culture (IVC) system used for preparing, holding and transferring human gametes or embryos during vaginal in vitro fertilization or intravaginal culture procedures (IVF/IVC). The INVOcell system consists of various components: INVOcell Culture Device, INVOcell Retention Device and INVOcell Holding Block. The INVO Procedure is a fertility treatment option allowing fertilization and early embryo development to take place inside the woman's body. The INVO Procedure is an IVC or in vivo incubation assisted reproduction technique available.

Officers and directors

Kathleen T. Karloff Chairman of the Board, President, Chief Executive Officer
Age: 61
Robert J. Bowdring Chief Financial Officer, Treasurer, Secretary, Director
Age: 59
Kevin Doody Director